XML 32 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
Basis of Presentation and Summary of Significant Accounting Policies (Details 3) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2012
Dec. 31, 2011
Sep. 30, 2011
Dec. 31, 2010
Sep. 30, 2012
Sales Revenue, Net
Revenue Concentration Risk
Takeda Pharmaceutical Company Limited (outside the U.S.)
Sep. 30, 2011
Sales Revenue, Net
Revenue Concentration Risk
Takeda Pharmaceutical Company Limited (outside the U.S.)
Sep. 30, 2012
Sales Revenue, Net
Revenue Concentration Risk
AmerisourceBergen Drug Corporation.
Sep. 30, 2011
Sales Revenue, Net
Revenue Concentration Risk
AmerisourceBergen Drug Corporation.
Sep. 30, 2012
Sales Revenue, Net
Revenue Concentration Risk
McKesson Corporation
Sep. 30, 2011
Sales Revenue, Net
Revenue Concentration Risk
McKesson Corporation
Sep. 30, 2012
Sales Revenue, Net
Revenue Concentration Risk
Cardinal Health, Inc
Sep. 30, 2011
Sales Revenue, Net
Revenue Concentration Risk
Cardinal Health, Inc
Sep. 30, 2012
Sales Revenue, Net
Revenue Concentration Risk
GPO
Sep. 30, 2012
Sales Revenue, Net
Geographical Concentration Risk
Sep. 30, 2011
Sales Revenue, Net
Geographical Concentration Risk
Investment Concentration Risk                              
Cash, cash equivalents and investments $ 210,800,000                            
Investment in institutional money market funds 41,500,000                            
Cash and cash equivalents 42,900,000 63,474,000 75,777,000 112,646,000                      
Amount invested in a single money market fund collateralized by U.S. treasury and government agency securities 21,400,000                            
Clinical trial accruals                              
Reduction of clinical trial accruals as the result of an error in estimated clinical trial costs $ 300,000                            
Customers representing 10% or more of revenues                              
Percentage of revenues from major customer         31.00% 13.00% 34.00% 42.00% 17.00% 20.00% 11.00% 12.00% 33.00%    
Percentage of revenues From customers outside of the U.S.                              
Approximate percentage of revenues from customers outside the U.S.                           32.00% 15.00%